ÂÜÀòÂÒÂ×

Benjamin Blaha is a highly experienced professional in bioprocess development and management, currently serving as Co-CEO, CTO, and co-founder at Fuse Vectors since August 2022. Prior experience includes holding the Vice President CMC role at ImmuneBridge, where Benjamin set up crucial departments and defined the CMC roadmap. As a consultant for NecstGen, expertise was provided in process development and training in Design of Experiments. Benjamin's tenure at uniQure involved leading a team of fifteen in early-stage CMC projects, while previous roles at the Cell and Gene Therapy Catapult and University College London further solidified skills in manufacturing processes and academic research. Educational qualifications consist of a PhD in Biochemical Engineering from UCL, along with advanced degrees in the same field and a bachelor's degree in Pharmaceutical Sciences.